Glioblastoma stem cell antigens (GSC antigens)

Glioblastoma stem cell (GSC) antigens are a diverse group of molecular markers and signaling proteins expressed by a subpopulation of tumor cells known as glioblastoma stem cells (Frontiers in Oncology, 2021). These cells are characterized by their capacity for self-renewal, multilineage differentiation, and resistance to standard therapies, which drives tumor recurrence and progression in glioblastoma multiforme (GBM) (MDPI, 2022). Key antigens include surface proteins such as CD133 (Prominin-1), CD44, and L1CAM, as well as intracellular factors like Nestin and SOX2 (Biomol, 2023). Therapeutic interventions targeting these antigens include dendritic cell vaccines (e.g., ICT-107), chimeric antigen receptor (CAR) T-cell therapies, and small molecule inhibitors targeting stemness pathways like STAT3 and Notch (MDPI, 2022; MDPI, 2023). These treatments aim to eliminate the tumor-initiating cell population that often survives conventional surgery, radiation, and chemotherapy (PMC, 2015). However, the clinical application of these therapies is challenged by the high degree of intratumoral heterogeneity and the immunosuppressive microenvironment of the brain (PMC, 2018). Additionally, the potential for off-target toxicity against normal neural stem cells remains a significant safety concern (Anatomy & Cell Biology, 2015). Overcoming the blood-brain barrier is another critical hurdle for delivering drugs that target these antigens effectively (MDPI, 2022).

Other names

Glioblastoma stem-like cell antigensGSC markersGlioma stem cell antigensGSC surface markersGlioblastoma multiforme stem cell-associated antigens

Targeting glioblastoma stem cell antigens involves diverse mechanisms, primarily immunotherapeutic approaches like dendritic cell vaccines and CAR-T cells that prime the immune system to recognize and destroy GSCs. Additionally, small molecule inhibitors are used to block intracellular signaling pathways, such as STAT3, Notch, and Wnt/beta-catenin, which are essential for maintaining the stem-like properties and self-renewal of these cells.